Company intelligence / Profile preview

BioAxis Research

Oss, Netherlandsbioaxisresearch.com ↗
Ownership
Private
Employees
~10
Development stage
Other
01

Overview

BioAxis Research enables rapid hit-to-lead and lead optimization for drug discovery using advanced computational and cheminformatic tools. The company supports early-stage research and optimization, but is not directly running clinical-stage programs for its own drugs.

Modalities
Small moleculeBiologicmRNA-based drugsAntibody
Industry
Drug Discovery Services
02

Partnerships

3D-e-Chem consortium (CMBI/Radboudumc, Netherlands eScience Center, Vrije Universiteit Amsterdam)European pharma and screening centersUK charitiesMKB Innovatiestimulering topsectoren Zuid-Nederland (Stimulus funding)

Beyond the preview

Go deeper on BioAxis Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioAxis Research.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call